Strides Pharma to direct preliminaries in India for potential COVID-19 medication Kumar Jeetendra | May 21, 2020 Indian pharmaceutical organization Strides Pharma Science Ltd said on Thursday it has acquired administrative endorsement to direct clinical preliminaries of antiviral medication favipiravir, a potential treatment for COVID-19. The organization has gotten endorsement from the Drug Controller General of India to direct preliminaries of favipiravir in the nation, Strides Founder and Non-Executive Chairman Arun Kumar …
Cipla receives final approval for generic version of Migranal® Kumar Jeetendra | May 21, 2020 Mumbai, India; May 21, 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (“ANDA”) for Dihydroergotamine Mesylate Nasal Spray 4mg/mL from the United States Food and Drug Administration (U.S. FDA) with a Competitive Generic Therapy (“CGT”) …
Dr. Reddy’s ascents after Hyderabad office gets EIR from USFDA Kumar Jeetendra | May 20, 2020 Dr. Reddy’s Laboratories rose 0.71% to Rs 3725.7 after the organization said its definitions producing plant – 3 at Bachupally in Hyderabad got the foundation examination report (EIR) from US medicate controller. Dr. Reddy’s will report Q4 results today, 20 May 2020. The medication creator revealed a united total deficit of Rs 538.40 crore in …
Adage and Pfizer knock up Amplyx’s series C to top $90 million Kumar Jeetendra | May 20, 2020 Amplyx Pharmaceuticals, a biotech organization creating imaginative treatments for incapacitating and perilous sicknesses in patients with traded off insusceptible frameworks, today reported that it has shut a $53 million Series C augmentation, which brings the Series C round to over $90 million. The financing was driven by Sofinnova Investments, with support from existing speculators including …
Laurus Labs gets USFDA endorsements for ANDAs TLE 400 and TLE 600 tablets Kumar Jeetendra | May 19, 2020 Laurus Labs Ltd. (Laurus BSE: 540222, NSE: Lauruslabs, ISIN: INE947Q01010) Laurus Labs Ltd is satisfied to declare that the Company has gotten an endorsement from USFDA under PEPFAR (President’s Emergency Plan for AIDS Relief) for two ANDAs (Abbreviated New Drug Application) TLE 400 (Tenofovir/Lamivudine/Efavirenz – 300/300/400mg) and TLE 600 (Tenofovir/Lamivudine/Efavirenz – 300/300/600mg) tablets. Laurus Labs …
Authorized Generic Version of Apriso® Launched by Lupin Kumar Jeetendra | May 19, 2020 Pharma significant Lupin Limited (Lupin) declared the dispatch of approved nonexclusive adaptation of Bausch Health’s Apriso® (Mesalamine Extended-Release Capsules 0.375 g) in the U.S. Mesalamine Extended-Release Capsules 0.375 g (approved nonexclusive form) are shown for the support of abatement of ulcerative colitis in patients 18 years old and more seasoned. Mesalamine Extended-Release Capsules 0.375 g, …
Lincoln Pharmaceuticals Ltd receives European Union (EU) GMP approval Kumar Jeetendra | May 19, 2020 May 19, 2020: Lincoln Pharmaceuticals Limited, one of India’s leading healthcare companies has received the European Union (EU) GMP certification from Germany FDA for its manufacturing facility located at Khatraj in Gujarat. The certification will allow the company to market its products in all the 27 member countries of EU and also give access to …
Cipla files ANDA for generic version of GSK’s Advair Diskus® Kumar Jeetendra | May 18, 2020 Mumbai, India; May 18, 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced its submission of an Abbreviated New Drug Application (ANDA) for Fluticasone propionate and Salmeterol inhalation powder (100/50 mcg, 250/50 mcg and 500/50 mcg) to the United States Food and Drug Administration (USFDA). The Company had …
Zydus Cadila gets provisional endorsement from USFDA for Droxidopa Capsules, 100 mg, 200 mg, and 300 mg Kumar Jeetendra | May 16, 2020 Zydus Cadila has gotten provisional endorsement from the USFDA to advertise Droxidopa Capsules, (US RLD: Northera®) in the qualities of 100 mg, 200 mg, and 300 mg. Droxidopa is utilized to treat indications of low pulse when standing, brought about by a specific ailment (neurogenic orthostatic hypotension-nOH). This drug can diminish indications of low circulatory …
FDA warns About Accuracy of Widely Used Abbott COVID-19 test Kumar Jeetendra | May 16, 2020 The Food and Drug Administration is forewarning people in general about the unwavering quality of a broadly utilized quick test for the coronavirus. The test, made by Abbott Laboratories, has been connected with mistaken outcomes that could dishonestly promise patients that they are not contaminated with the infection. The Trump organization has advanced the test …
Cipla announces its Q4 FY20 results demonstrating sustained growth momentum across core businesses and unlocking of respiratory pipeline Kumar Jeetendra | May 15, 2020 Mumbai, May 15, 2020: Cipla Limited (BSE: 500087, NSE: CIPLA) today announced its audited consolidated financial results for quarter ended March 31st, 2020. Key highlights of the quarter: India: The Rx business grew by 12% on a y-o-y basis recording a 3rd consecutive quarter of market beating growth. The trade Gx business revives strongly recording …
Sanofi says COVID-19 antibody will be accessible overall at the same time Kumar Jeetendra | May 15, 2020 Sanofi will guarantee that a potential antibody against COVID-19, whenever affirmed, arrives at all locales of the world simultaneously, the administrator of the French drugmaker said on Thursday. “There will be no specific development given to any nation,” Serge Weinberg disclosed to France 2 TV. “We are sorted out with a few assembling units. Some …
